Marc Feiglin is currently Chief Technology Officer at Excelsior Sciences where he is responsible for leading efforts relating to laboratory automation and informatics technologies. Prior to Excelsior, Marc was Head of Innovative Technologies at Deerfield Discovery & Development Corporation (3DC) where he headed efforts relating to acquiring and developing innovative technologies which enable drug discovery.

Prior to Deerfield, Marc was Senior Director for External Innovation and Strategy & Corporate Development at Thermo Fisher Scientific where he led cross-functional efforts to develop new corporate capabilities for external equity investment and partnering in life science tools, analytical technologies, diagnostics, and bioproduction.

Prior to Thermo Fisher, Marc worked at Merck KgaA of Germany focused on external partnerships and investments across the electronics, life sciences, and pharmaceutical industries. The positions he held included Global Head of Alliance Management & Partnerships for Merck’s Electronics Business Unit and as the local of Head Technology Scouting & Partnerships in Israel for Merck’s Life Sciences and Electronics units.

At Tecan Group, the leading provider of automation tools for the life sciences and diagnostics industries, Marc held a variety of roles in product development, marketing, strategy, corporate development, and as CTO. While at Tecan, he developed a novel microfluidic technology for which he was awarded over two dozen patents and built the technology into an internal start-up focused on point-of-care diagnostics.

Marc started his career as an enzymologist researching infectious diseases at Merck & Co. where he initially became interested in how to leverage innovation to improve early drug discovery and was an early implementor of automation for drug discovery.

Marc has been a very active in several professional organizations relating to the life science industry. He served as president of the Society for Biomolecular Sciences where he initiated the merger with the Association for Laboratory Automation to form what is today the Society for Laboratory Automation and Screening. Marc also led the efforts to draft and establish the initial standards for the microplate as recognized by the American National Standards Institute.

Marc holds an MBA jointly awarded by New York University Stern School of Business, London School of Economics and Political Science, and Hautes Etudes Commerciales School of Management (Paris) and a BS degree in Biology from the University of Michigan.